{"_id":"cK8NKXOMGmdzuEElGHXWxYQspJL62rsJKPnEdZPO1z6zb5TKk0yaoo","type":"Investor","logokey":"$Oq2n7OuDmwUSlKgk2jOybJCBuKXS08Ic377FWHRRG9W0a7rVrxC1v2.jpeg","name":"TCG X","subtype":"VC and Private Equity","lastupdate":"2023-09-19T00:00:00.000Z","update_date":"2023-09-19T00:00:00.000Z","lastModified":"Sep 19, 2023","active":1,"confidence_score":8,"confidence_score_reason":"funding stage, product stage, sector, founding year, founding month, number of employees, tags, invite member, business model, address, description, homepage, video or image, funding rounds, news, markets, external profiles, not claimed","urlname":"tcg-x","minimal_profile":1,"hide_reason":null,"status":"","fullstatus":null,"hide_reason_data":null,"acquired":null,"description_edited":null,"tag_line_edited":null,"isisraeli":0,"country":"United States","formernames":[],"min_date_investments":"2022-06-01T00:00:00.000Z","hide_reasons":[{"id":"71DetFrndkNwNZufhli91PBqJkgDvyWv0skK3yYHYitL6RnFpb2Uf1","reason":"Pending approval - External entity"},{"id":"bMlvNZGgO393OpCQn2LLGyGQIyzd4aZiwm516IvRMWEx6Fkam4LPsQ","reason":"Firm does not match any of Finder’s investors entities"},{"id":"hUspihf43qDmsZbgaEhZKEfAAW3v31Vgv8cpxJzOvLRPPTJ0F4MHzR","reason":"Pending approval"},{"id":"o9Wzo8oG7DIeZVpiC2CdK6IVPWAA4wFvEE97ITVY0oHo6HyeP4v2YV","reason":"Firm asked to delete"},{"id":"rW7l4bkGn6inVBM54t8wGMz9mlLAxGGZOgTQSofPoEagmlofSfwSil","reason":"Foreign, no presence - no Israeli investments/fund"},{"id":"TW4W1IZcqaOGz6jCahuX2wE03SdSzw54lheysaeW0zOAsmOGBFF014","reason":"Foreign, no presence - not enough investments"},{"id":"wcXeLKSl465vLdJtWXjddE1UVQbANeL8NjdsDpAh0CYTtOJw8wHP97","reason":"Firm asked to hide in the meantime"}],"registrar":null,"founded_year":null,"iia_supported":null,"currently_iia_supported":null,"alternativenames":null,"managedassets":"Undisclosed","representing":null,"supported_by":"","supported_by_id":"","inisraelsince":"","inisraelsincemonth":"","investment_lower_amount":null,"investment_upper_amount":null,"marketcapital":null,"marketcapitaldate":null,"oneliner":"science-driven investment firm dedicated to advancing disruptive medicines.","website":"","sociallinks":{"twitter":"","youtube":"","facebook":"","linkedin":"","instagram":""},"social":[],"flattenedsociallinks":null,"apps":{"appstore":"","googleplay":""},"investmentstage":[],"about":"science-driven investment firm dedicated to advancing disruptive medicines.","founded":"","education":null,"additional_activities":null,"events":null,"techcommunityinvolvement":null,"exits":[],"funds":[],"portfolio":[{"id":"mwIyeBDUmDOWp6IOwfCnJloFVvOCetd0l6ywOhH7XXM9Td4vXDuq6x","name":"Upstream Bio","hidden":true,"raised":"$400M","founded":"2021","fullurl":"/company_page/upstream-bio","logokey":"$S1eMMyVdFAExuHvwwSpBon8qRTQkHZY564h6FSgK1D5i6UuhNjDbcp.jpeg","urlname":"upstream-bio","employees":"11-50","description":"Monoclonal Antibody Drug for Asthma Patients","fundingstage":"B","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":400000000,"companyvisibility":"Private","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$S1eMMyVdFAExuHvwwSpBon8qRTQkHZY564h6FSgK1D5i6UuhNjDbcp.jpeg","style":"","hiddenCompanyTooltip":""}],"investments":[{"date":"Jun 2023","name":"Upstream Bio","amount":200000000,"hidden":true,"islead":0,"country":null,"eventid":"HhRArCFbsmug76Z9n55013qrLcsKa6uZq8j9qgEK20r8oBwKQqEHiV","fullurl":"/company_page/upstream-bio","logokey":"$S1eMMyVdFAExuHvwwSpBon8qRTQkHZY564h6FSgK1D5i6UuhNjDbcp.jpeg","tagline":"Monoclonal Antibody Drug for Asthma Patients","urlname":"/company_page/upstream-bio","companyid":"mwIyeBDUmDOWp6IOwfCnJloFVvOCetd0l6ywOhH7XXM9Td4vXDuq6x","isfollowon":1,"companytype":"Startup","eventamount":"$200M","fundingtype":"B Round","investmentid":"WzetdMaS5CBsUhrABW3flIbaW0kXN6jX3uJR8kNv7uEEqD2QhKzQgC","investoramount":null,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$S1eMMyVdFAExuHvwwSpBon8qRTQkHZY564h6FSgK1D5i6UuhNjDbcp.jpeg","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":null,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Jun 2022","name":"Upstream Bio","amount":200000000,"hidden":true,"islead":0,"country":null,"eventid":"MnK1VMAoT6FIYkGKoDG94miB1mSgfDKodZYw6bouKiFzxq1wEzZ3Wu","fullurl":"/company_page/upstream-bio","logokey":"$S1eMMyVdFAExuHvwwSpBon8qRTQkHZY564h6FSgK1D5i6UuhNjDbcp.jpeg","tagline":"Monoclonal Antibody Drug for Asthma Patients","urlname":"/company_page/upstream-bio","companyid":"mwIyeBDUmDOWp6IOwfCnJloFVvOCetd0l6ywOhH7XXM9Td4vXDuq6x","isfollowon":0,"companytype":"Startup","eventamount":"$200M","fundingtype":"A Round","investmentid":"3spPML2H7tk9smrdD6XpCjR4Wund6SlWd66ccGYMMZFDQx8BPisJB4","investoramount":null,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$S1eMMyVdFAExuHvwwSpBon8qRTQkHZY564h6FSgK1D5i6UuhNjDbcp.jpeg","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":null,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""}],"team":[],"tags":[],"targetmarkets":[],"phone":null,"address":{"israeli":[],"officesabroad":[]},"headquarter_address":null,"news":[],"newsNumber":0,"mediagallery":[],"biverification":null,"sectorverify":null,"biverify":null,"biverifydate":null,"crunchbaseid":null,"lastupdator":null,"lastupdator_email":null,"creator":"Matan Eblagon","creator_email":"matane@sncentral.org","createdate":"2023-09-19T00:00:00.000Z","recentupdates":[{"email":"matane@sncentral.org","source":"Manual","datetime":"2023-09-19 07:47:53.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"matane@sncentral.org","source":"Manual","datetime":"2023-09-19 07:47:53.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"matane@sncentral.org","source":"Manual","datetime":"2023-09-19 07:47:53.000000","last_name":"Eblagon","first_name":"Matan"}],"rounds_per_sector":[{"count":2,"sector":"Health Tech & Life Sciences"}],"rounds_per_stage":[{"count":1,"isfollowon":0,"fundingStage":"A Round"},{"count":1,"isfollowon":1,"fundingStage":"B Round"}],"investment_rounds_over_time":[{"year":2022,"month":6,"record_count":1},{"year":2023,"month":6,"record_count":1}],"portfolio_companies_per_sector":[{"count":1,"sector":"Health Tech & Life Sciences"}],"new_portfolio_companies_over_time":[{"year":2022,"month":6,"record_count":1}],"exits_over_time":null,"exits_by_sector":null,"affiliatedOrganizations":null,"timeline":[],"databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"VC and Private Equity","parsedName":"TCG X","logourl":"https://storage.googleapis.com/clean-finder-353810/$Oq2n7OuDmwUSlKgk2jOybJCBuKXS08Ic377FWHRRG9W0a7rVrxC1v2.jpeg","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$Oq2n7OuDmwUSlKgk2jOybJCBuKXS08Ic377FWHRRG9W0a7rVrxC1v2.jpeg","teamMembersNumber":0,"section":null,"sectionParams":"","queryParams":"","seoabout":"science-driven investment firm dedicated to advancing disruptive medicines.","seoTitle":"Foreign VC and Private Equity","serializedCharts":"{\"investmentsRoundsByRoundType\":[{\"fundingStage\":\"A Round\",\"newInvestments\":1,\"followOnInvestments\":0},{\"fundingStage\":\"B Round\",\"newInvestments\":0,\"followOnInvestments\":1}],\"investmentRoundsBySector\":[{\"count\":2,\"sector\":\"Health Tech & Life Sciences\"}],\"investmentRoundsOverTime\":[{\"label\":\"2022\",\"count\":1},{\"label\":\"2023\",\"count\":1},{\"label\":\"2024\",\"count\":0},{\"label\":\"2025\",\"count\":0},{\"label\":\"2026\",\"count\":0}],\"portfolioCompaniesBySector\":[{\"count\":1,\"sector\":\"Health Tech & Life Sciences\"}],\"portfolioCompaniesOverTime\":[{\"label\":\"2022\",\"count\":1},{\"label\":\"2023\",\"count\":0},{\"label\":\"2024\",\"count\":0},{\"label\":\"2025\",\"count\":0},{\"label\":\"2026\",\"count\":0}],\"exitsOverTime\":[],\"exitsBySector\":[]}","statusinfo":"","iiasupport":"","managedAssetsNumber":null,"investmentrange":"$200M - $200M","communityinvolvement":[],"foreignInvestments":"","nationality":"Foreign","investorStatistics":{"exitRatio":{"amount":"0"},"investmentFollowOnRatio":{"amount":""},"leadInvestorShare":{"amount":"0"},"soloInvestmentRoundRatio":{"amount":"0"},"firstInvestorRatio":{"amount":"0"}},"popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none"},"mainContact":{}}